Work

Prognostication using molecular (mol) markers and clinicopathological (clpath) features in high-risk stage II/III colon cancer (CC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.3519

Authors: Rodrigo Dienstmann, Sabine Tejpar, Frank A. Sinicrope, Amanda I. Phipps, Brian Bot, Stephen Henry Friend, Mauro Delorenzi, Polly A. Newcomb, Daniel J. Sargent, John M Jessup, Justin Guinney

Institutions: Sage Bionetworks, KU Leuven, Mayo Clinic, Fred Hutch Cancer Center, Centre Hospitalier Universitaire Vaudois, National Cancer Institute

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890111417

Cites:

Cited by:

Related to: 10